Grupo Fleury
Ester Brito Oliveira serves as an Analista de Laboratório I at Grupo Fleury since July 2023, specializing in the marking of monoclonal antibodies for oncohematological diagnoses and cellular therapy evaluations. Previous experience includes roles as a Técnico de laboratório and Auxiliar de Laboratório at SPDM, where responsibilities encompassed the pre-analytical analysis of biological samples, communication of critical results, and performance of various laboratory tests. Ester's earlier roles include an internship at Hospital Geral da Vila Penteado, focusing on quality control in biochemistry and hematology, and at FEMME - Laboratório da Mulher, providing patient care and assistance in ultrasound examinations. Educational qualifications include a Postgraduate degree in Hematology, Hemotherapy, and Cell Therapy from Centro Universitário São Camilo and a degree in Biomedicine from Universidade São Judas Tadeu, complemented by technical training in Occupational Safety from ETEC.
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.